Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2025-12-25 @ 5:14 PM
Study NCT ID:
NCT03481803
Status:
COMPLETED
Last Update Posted:
2018-09-28
First Post:
2018-03-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase IIa Study With Escalating Dose of MS1819-SD
Sponsor:
AzurRx SAS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-27
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-06-29
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-06
First Submit QC Date:
None
Study First Post Date:
2018-03-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-27
Last Update Post Date:
2018-09-28
Last Update Post Date Type:
ACTUAL